Age-Dependent Rescue by Simvastatin of Alzheimer's Disease Cerebrovascular and Memory Deficits
Open Access
- 4 April 2012
- journal article
- research article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 32 (14), 4705-4715
- https://doi.org/10.1523/jneurosci.0169-12.2012
Abstract
Alzheimer's disease (AD) is now established as a progressive compromise not only of the neurons but also of the cerebral vasculature. Increasing evidence also indicates that cerebrovascular dysfunction may be a key or an aggravating pathogenic factor in AD, emphasizing the importance to properly control this deficit when aiming for effective therapy. Here, we report that simvastatin (3–6 months, 40 mg/kg/d) completely rescued cerebrovascular reactivity, basal endothelial nitric oxide synthesis, and activity-induced neurometabolic and neurovascular coupling in adult (6 months) and aged (12 months) transgenic mice overexpressing the Swedish and Indiana mutations of the human amyloid precursor protein (AD mice). Remarkably, simvastatin fully restored short- and long-term memory in adult, but not in aged AD mice. These beneficial effects occurred without any decreasing effect of simvastatin on brain amyloid-β (Aβ) levels or plaque load. However, in AD mice with recovered memory, protein levels of the learning- and memory-related immediate early genes c-Fos and Egr-1 were normalized or upregulated in hippocampal CA1 neurons, indicative of restored neuronal function. In contrast, the levels of phospholipase A2, enkephalin, PSD-95, synaptophysin, or glutamate NMDA receptor subunit type 2B were either unaltered in AD mice or unaffected by treatment. These findings disclose new sites of action for statins against Aβ-induced neuronal and cerebrovascular deficits that could be predictive of therapeutic benefit in AD patients. They further indicate that simvastatin and, possibly, other brain penetrant statins bear high therapeutic promise in early AD and in patients with vascular diseases who are at risk of developing AD.Keywords
This publication has 69 references indexed in Scilit:
- Scavenger receptor CD36 is essential for the cerebrovascular oxidative stress and neurovascular dysfunction induced by amyloid-βProceedings of the National Academy of Sciences of the United States of America, 2011
- Statins Promote the Degradation of Extracellular Amyloid β-Peptide by Microglia via Stimulation of Exosome-associated Insulin-degrading Enzyme (IDE) Secretion*Journal of Biological Chemistry, 2010
- Age‐Varying Association Between Statin Use and Incident Alzheimer's DiseaseJournal of the American Geriatrics Society, 2010
- Intact Memory in TGF-β1 Transgenic Mice Featuring Chronic Cerebrovascular Deficit: Recovery with PioglitazoneJournal of Cerebral Blood Flow & Metabolism, 2010
- Simvastatin enhances hippocampal long-term potentiation in C57BL/6 miceNeuroscience, 2010
- β-Amyloid Impairs AMPA Receptor Trafficking and Function by Reducing Ca2+/Calmodulin-dependent Protein Kinase II Synaptic DistributionJournal of Biological Chemistry, 2009
- Brain Glucose Hypometabolism and Oxidative Stress in Preclinical Alzheimer's DiseaseAnnals of the New York Academy of Sciences, 2008
- Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's diseaseNature Neuroscience, 2008
- Simvastatin attenuation of cerebral vasospasm after subarachnoid hemorrhage in rats via increased phosphorylation of Akt and endothelial nitric oxide synthaseJournal of Neuroscience Research, 2008
- Nox2-derived radicals contribute to neurovascular and behavioral dysfunction in mice overexpressing the amyloid precursor proteinProceedings of the National Academy of Sciences of the United States of America, 2008